OSR Health (OSRHW) Cash from Operations (2022 - 2026)
OSR Health (OSRHW) posted Cash from Operations of 1001956.92 for Q1 2026, up 6.36% sequentially from 1069993.0 in Q4 2025, and down 1463.86% YoY from 73464.55 in Q1 2025.
OSR Health (OSRHW) Cash from Operations (2022 - 2026) Analysis & Trends
OSR Health has reported Cash from Operations for 5 years, with the latest figure at 1001956.92 in Q1 2026.
- Quarterly Cash from Operations fell 1463.86% year-over-year to 1001956.92 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5265921.63 (down 272.21% YoY) and the FY2025 annual result came in at 4328034.0, down 134.01% from the prior year.
- Cash from Operations climbed to 1001956.92 in Q1 2026 per OSRHW's latest filing, from 1069993.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 3790.0 in Q3 2022 and troughed at 2711363.0 in Q3 2025.
- A 5-year average of 500146.24 and a median of 313557.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations slumped 29258.51% in 2023, then jumped 87.15% in 2025.
- Over 5 years, Cash from Operations stood at 952.0 in 2022, then plunged by 29258.51% to 279493.0 in 2023, then jumped by 35.23% to 181030.0 in 2024, then sank by 491.06% to 1069993.0 in 2025, then gained by 6.36% to 1001956.92 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1001956.92, 1069993.0, and 2711363.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 728.46 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -88.83 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Jun 30, 2025 | -482,608.71 |
| Jun 30, 2025 | -482,608.71 |
| Mar 31, 2025 | -64,069.29 |
| Mar 31, 2025 | -64,069.29 |
| Dec 31, 2024 | -181,030.00 |
| Dec 31, 2024 | -181,030.00 |
| Sep 30, 2024 | -686,453.00 |
| Sep 30, 2024 | -686,453.00 |
| Jun 30, 2024 | -483,215.00 |
| Jun 30, 2024 | -483,215.00 |
| Mar 31, 2024 | -498,776.00 |
| Mar 31, 2024 | -498,776.00 |
| Dec 31, 2023 | -279,493.00 |
| Dec 31, 2023 | -279,493.00 |